iRhythm to acquire Vital Connect for $287.5M in cash and stock

Filed August 6, 2026 · Period ending August 5, 2026 · ~1 min read

Key Changes

• high

  iRhythm entered into a definitive agreement to acquire Vital Connect for $287.5M total consideration: $237.5M cash plus $50M in iRhythm stock, with Vital Connect becoming a wholly owned subsidiary upon closing.

  Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
• medium

  iRhythm will provide up to $30M in interim funding to Vital Connect before closing, starting with an initial $10M grant, to support operations during the regulatory review period.

  Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
• medium

  The acquisition is expected to close by year-end 2026, subject to Vital Connect shareholder approval and HSR antitrust clearance; iRhythm will pay a $9M reverse termination fee if the deal fails due to antitrust issues.

  Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →